InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
56%
T+90 mean return
+9.6%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by ROMANO KATHRYN, Chief Accounting Officer. Director active across 1 company, notably Krystal Biotech, Inc.. Aggregated, 10 reports have been recorded. Activity tracked since 26 February 2022. The latest transaction was disclosed on 27 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
7,500 shares0Common StockSEC:0001801385-26-000002:0
7,500 shares0Common StockSEC:0001801385-26-000002
2,268 shares@ US$176.3955.1% of flowCommon StockSEC:0001801385-25-000002:0
523 shares@ US$63.554.4% of flowCommon StockSEC:0001801385-24-000009:0
648 shares@ US$63.555.5% of flowCommon StockSEC:0001801385-24-000011:0
5,000 shares@ US$52.2635.0% of flowCommon StockSEC:0001801385-24-000007:0
2,500 shares@ US$52.2612.4% of flowCommon StockSEC:0001801385-24-000002:0
12,500 shares@ US$52.2662.7% of flowCommon StockSEC:0001801385-23-000004:0
2,144 shares@ US$78.4616.4% of flowCommon StockSEC:0001801385-23-000002:0
1,472 shares@ US$62.500.0011% mcap100.0% of flowCommon StockSEC:0001801385-22-000005:0
10 of 10 declarations
About ROMANO KATHRYN
Kathryn Romano is the Chief Accounting Officer at Krystal Biotech, Inc. She is responsible for overseeing the accounting and financial operations of the company. Romano plays a key role in managing financial resources and in developing financial reports that comply with standards.
